Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Peripheral Primitive Neuroectodermal Tumor”

349 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 349 results

Not applicableStudy completedNCT00020527
What this trial is testing

Caspofungin Acetate in Treating Children With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionKidney Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003737
What this trial is testing

Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00070109
What this trial is testing

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Who this might be right for
Previously Treated Childhood RhabdomyosarcomaRecurrent Childhood RhabdomyosarcomaRecurrent Childhood Soft Tissue Sarcoma+2 more
Children's Oncology Group 50
Testing effectiveness (Phase 2)Study completedNCT02116777
What this trial is testing

Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies

Who this might be right for
Adult Solid NeoplasmChildhood Solid NeoplasmRecurrent Childhood Central Nervous System Neoplasm+3 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Looking for participantsNCT06674265
What this trial is testing

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Who this might be right for
Neuroblastoma, Recurrent, RefractoryNeuroblastoma (NB)Neuroblastoma in Children
Marzieh Ebrahimi 10
Early research (Phase 1)Study completedNCT00994071
What this trial is testing

A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors

Who this might be right for
MedulloblastomaPontine GliomaEpendymoma+2 more
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT01875601
What this trial is testing

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Who this might be right for
Solid TumorsBrain TumorsSarcoma+2 more
National Cancer Institute (NCI) 16
Early research (Phase 1)Study completedNCT00049023
What this trial is testing

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsGastrointestinal Carcinoid TumorIslet Cell Tumor+4 more
O'Dorisio, M S 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Testing effectiveness (Phase 2)Looking for participantsNCT06836505
What this trial is testing

Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.

Who this might be right for
Neuroblastoma (NB)Desmoplastic Small Round Cell Tumor (DSRCT)
Sun Yat-Sen University Cancer Center 10
Early research (Phase 1)Looking for participantsNCT02508038
What this trial is testing

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more
University of Wisconsin, Madison 22
Not applicableStudy completedNCT00248547
What this trial is testing

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

Who this might be right for
Cancer
OHSU Knight Cancer Institute 40
Testing effectiveness (Phase 2)Study completedNCT00118326
What this trial is testing

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Who this might be right for
Kidney CancerLeukemiaLymphoma+3 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Early research (Phase 1)Study completedNCT02982941
What this trial is testing

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteosarcoma+3 more
MacroGenics 25
Testing effectiveness (Phase 2)Ended earlyNCT01505608
What this trial is testing

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Giselle Sholler 14
Testing effectiveness (Phase 2)Study completedNCT00276679
What this trial is testing

Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Children's Cancer and Leukaemia Group
Not applicableWithdrawnNCT01558778
What this trial is testing

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more
Roswell Park Cancer Institute
Next Page